BioFilm Control

About:

BIOFILM has developed a proprietary technology of microbiological diagnostics.

Website: http://www.biofilmcontrol.com/en/

Top Investors: Entrepreneur Venture, Sofimac Investment Managers

Description:

BioFilm Control is a Biotechnology R&D company, formed in 2004, which has developed one-of-a-kind proprietary technology using magnetisable microbeads, protected by 7 patents and 9 trademarks. This technology detects the biofilm behaviour of microorganisms and was automated in 2009. This is the only “biofilm” technology in Medical Analysis Laboratories (Public or Private institutions). BioFilm Control markets BioFilm Ring Test® and Antibiofilmogram® kits in 96-well plate format for research use only. The Antibiofilmogram® kits study the susceptibility of bacteria to antibiotics, both in planktonic and biofilm populations. Three panels of 11 antibiotics are available, defined for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. Clinical protocols are under way and the first MD-IVD versions with CE marking are scheduled for 2017.

Total Funding Amount:

3M EUR

Headquarters Location:

Saint-beauzire, Auvergne, France

Founded Date:

2005-01-01

Contact Email:

contact(AT)biofilmcontrol.com

Founders:

Thierry Bernardi

Number of Employees:

11-50

Last Funding Date:

2014-12-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai